Skip to content

Global study presents first results on the longer-term effects of therapies for the treatment of critically ill patients with COVID-19

By Gold Cross - December 20, 2022

Covid-19
This article is only available to ITK members and is restricted for Pharmacists. Please or Register as a Pharmacist to read the content.
Share this article:
Article tags

Articles you might be interested in

Pharmacist Only

New survey shows significant gaps in Australians understanding of iron deficiency

Gold Cross | November 24, 2023
,

Higher proportion of Australians live with a chronic health condition, impacting employment opportunities

Gold Cross | November 23, 2023
Pharmacist Only

Extreme pollen: Tip tops for pharmacists and data on Aussies ‘sneez-iety’ habits

Gold Cross | November 21, 2023
,

Regional and remote Australians urged to get late flu vaccine

Gold Cross | November 21, 2023
BD Rowa automation gives you back 6 hours in your day

Latest Posts

We stand ready to help more patients
Gold Cross | November 29, 2023
New Board members at National Rural Health Alliance
Gold Cross | November 29, 2023
Premier Chris Minns expands pharmacy trial as 6000 women bypass GPs for over-the-counter consults
Gold Cross | November 28, 2023

Featured Posts

Gold Cross parts ways with Kings Transport
Gold Cross | November 28, 2023
Cost of living now costing our health
Gold Cross | November 21, 2023
Pharmacy firsts
Gold Cross | November 17, 2023

Tags

Scroll To Top